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Figure 1. Analysis of informaƟon on motor performance provided by referral. 
(a) Specialist consultants provide informaƟon on motor performance 
signiﬁcantly more oŌen than GPs and other doctors (χ²(1)=6.36, p=0.012) (n=99). 
(b) In ~50% of cases where the referral leƩer indicated no motor impairment, 
there was signiﬁcant motor impairment according to EMAS (score > 14). Note 
that all EMAS were carried out within 6 months of the referral (n=48).  
The Edinburgh Motor Assessment (EMAS) was introduced in 2013 at the Anne Rowling Clinic in Edinburgh as a brief motor screening tool to assess motor dysfuncƟon in 
demenƟa paƟents1. It consists of 33 items, which are rated on a scale of 0 (no impairment) to 3 (signiﬁcant impairment), and assigned to 1 of 4 motor domains 
(extrapyramidal, amyotrophic, cerebellar, or complex). EMAS is scored out of 99 points and on the basis of the distribuƟon of data in normal controls an abnormal score is 
deﬁned as a score higher than 142. On average EMAS takes 6min1 to complete in clinical pracƟce, and it has been carried out for 226 paƟents.  
1. Do the 33 items measure the same underlying construct, i.e. motor ability? 
Internal consistency was assessed using all EMASes (n=364) 
→ Cronbach‘s α = 0.92 
 
2. How good is the agreement between raters? 
Interrater reliability was assessed using scores from two diﬀerent raters (n=91) 
for each item & the total EMAS score 
→ For items: average Krippendorﬀ‘s α = 0.62 
→ For EMAS total score: ρ = 0.911**  
Figure 3. Mean total EMAS score for diagnosƟc groups (n=118). Motor FTD paƟents 
have a signiﬁcantly higher mean score compared to all other diagnosƟc groups 
(Kruskal Wallis  χ²(4)=23.03, p<0.001). **signiﬁcant at p < 0.01, all error bars are SEM. 
We compared performance on EMAS between paƟents diagnosed with 
mild cogniƟve impairment (MCI), Alzheimer‘s disease (AD) and the 
three variants of frontotemporal demenƟa (FTD):  
Figure 4. Motor proﬁles for diagnosƟc groups (n=118). On the extrapyramidal 
and complex domains motor FTD paƟents have a higher score than all other 
diagnosƟc groups paƟents (Kruskal Wallis  with Dunn Bonferroni post-hoc χ²(4)
=23.29, p<0.001, and χ²(4)=16.87, p<0.01, respecƟvely). 
Item 
Factor Loading Extracted 
communality 1 2 3 4 5 
Fist/ palm 0.839     0.717 
Limb apraxia 0.815     0.641 
PronaƟon/ supinaƟon 0.809     0.679 
Luria 3-step 0.674     0.438 
Finger-nose test 0.423   0.346 0.212 0.398 
Eyes extrapyramidal 0.416  0.408   0.548 
Rigidity 0.332     0.346 
Bradykinesia 0.317  0.272 0.310 0.264 0.606 
WasƟng Upper limbs   0.693    0.457 
WasƟng Mouth-tongue  0.388    0.188 
Weakness  0.297  0.237 0.205 0.275 
Gait & Tandem Gait    0.833   0.800 
Balance/ retropulsion   0.705   0.506 
Dysarthria   0.440   0.287 
Signe d’applaudissement   0.412  0.219 0.342 
Dysdiadochokinesia 0.273  0.297 0.263 0.267 0.572 
Tremor     0.462  0.278 
Involuntary movements     0.355  0.159 
Orobuccofacial apraxia     0.453 0.322 
Nystagmus     0.389 0.143 
Eigenvalues 4.403 1.319 3.723 1.549 1.875  
Figure 2. Results from the exploratory factor analysis (n=364). A principal axis 
factor analysis on 20 items with an oblique rotaƟon idenƟﬁed ﬁve factors (KMO 
= 0.87, BartleƩ‘s p < 0.05). InterpretaƟon of the ﬁve factors: Factor 1 = complex 
movements; Factor 2 = motor funcƟons of the amyotrophic domain; Factor 3 = motor symptoms 
related to progressive supranuclear palsy; Factor 4 =  motor funcƟons of the extrapyramidal & 
cerebellar domain; Factor 5 = motor funcƟons related to apraxia.  
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(a) (b) 
** 
1. There is much need for EMAS in clinic pracƟce 
2. EMAS appears to be a reliable tool with a valid mulƟdimensional format 
3. Motor impairments occur in paƟents with Alzheimer‘s disease and 
frontotemporal demenƟas, but they do not appear to be diagnosis-speciﬁc 
→ Previous work showed that most clinicians do not assess motor 
funcƟons in demenƟa paƟents3 
